机构:[1]Department of Neurosurgery, Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, 510095, China[2]State Key Laboratory of Respiratory Disease, The 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China[3]Department of Physiology, School of Basic Science, Guangzhou Medical University, Guangzhou, Guangdong, 510182, China[4]Guangdong Provincial Hospital of TCM Breast Department, Guangzhou, Guangdong, 510006, China广东省中医院
Lactate dehydrogenase A (LDHA) is involved in various cancers. In this study, we investigated the expression and function of LDHA in glioma. We found that LDHA was up-regulated in glioma samples. Furthermore, we found that overexpression of LDHA promoted proliferation, invasion and glycolysis in glioma cells. Luciferase reporter assays confirmed that LDHA was a direct target of miR-200b. miR-200b was found to be down-regulated in glioma samples, which was inversely correlated with LDHA expression. Repression of LDHA by miR-200b suppressed the glycolysis, cell proliferation and invasion of glioma cells. These results provide evidence that miR-200b acts as a tumor suppressor in glioma through the inhibition of LDHA both in vitro and in vivo. Targeting LDHA through miR-200b could be a potential therapeutic strategy in glioma.
基金:
Youth
Project of Guangzhou Medical University (2013A38) and
The Scientific Research Project of Guangzhou Municipal
University (1201430219).
第一作者机构:[1]Department of Neurosurgery, Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, 510095, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Hu Su,Jiang Qian,Luo Dongdong,et al.miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma[J].ONCOTARGET.2016,7(30):48423-48431.doi:10.18632/oncotarget.10301.
APA:
Hu, Su,Jiang, Qian,Luo, Dongdong,Zhao, Lei,Fu, Xin...&Peng, Biao.(2016).miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.ONCOTARGET,7,(30)
MLA:
Hu, Su,et al."miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma".ONCOTARGET 7..30(2016):48423-48431